Cure My Disease

Don't miss your cure!

Log in / Sign up

Macular telangiectasia

MONDO:1010184

An eye disorder characterized by retinal capillary network incompetence, dilatations, and thinning which can be uniocular or binocular and causes gradual deterioration of central vision.

3 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Sub-types

Macular telangiectasia type 2 (2) Macular telangiectasia type 1 (1) Macular telangiectasia type 3 (0)

Broader categories

Disease (717) Eye disorder (104) Human disease (15) Disorder of orbital region (3) Disorder of visual system (1) Disease by body system or component (0)

Trials to join now! 1 Not yet recruiting 1 Terminated 1

Eye drug trial for rare macular disease stops early – only 16 patients enrolled

Disease control Stopped early

This phase 3 trial tested aflibercept (Eylea) eye injections against placebo in 16 people with macular telangiectasia type 1, a rare condition that causes vision loss. The study aimed to see if aflibercept could reduce swelling in the macula. However, the trial was terminated ear…

Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC